Diabetic retinopathy and maculopathy;Diabetische retinopathie und makulopathie

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 20, 2006, Pages 1173-1175

  Hammes, H P ^a   Lemmen, K D ^b   Jochmann, C ^c   Wiedemann, P ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Augenklinik   (Germany)

^c Abteilung für Pneumologie Medizinische Klinik und Poliklinik   (Germany)

Author keywords

Diabetic retinopathy; Maculopathy; Screening

Indexed keywords

DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; NOTE; RETINA MACULOPATHY; SCREENING; ARTICLE; HUMAN; RETINA MACULA DEGENERATION; TREATMENT OUTCOME;

DIABETIC RETINOPATHY; HUMANS; MACULAR DEGENERATION; TREATMENT OUTCOME;

EID: 33745995737     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941746     Document Type: Note

References (16)

1. Degenring RF, Kreissig I, Jonas BJ. Intraokulare Triamcinolongabe bei diffusem diabetischen Makulaödem. Ophthalmologe 2004; 101: 251-254
2. Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol 1990; 108: 958-964
3. Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membane in chronic diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2004; 242: 630-637
4. Early Treatment Diabetic Retinopathy Study (ETDRS) Group. Results and summary. Ophthalmology 1991(Suppl 598: 739-840
5. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58
6. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393
7. Hörle S, Gruner F, Kroll P. Epidemiologie diabetischer Erblindungen- eine Übersicht. Klin Monatsbl Augenheilkd 2002; 219: 777-784
8. Jonas BJ, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophhthalmol 2001; 132: 425-427
9. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 2000; 102: 7-16
10. Lang GE. Medikamentöse Therapie der diabetischen Retinopathie. Ophthalmologe 2004; 101: 1165-1170
11. Lenfant C. Shattuck lecture: clinical research to clinical practice - lost in translation? N Engl J Med 2003; 349: 868-874
12. Malone JI, Morrison AD, Pavan PR, Cuthbertson DD. Diabetic Control and Complications Trial. Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care 2001; 24: 522-526
13. Microvascular and acute complications in IDDM patients: the EURODIAB Complications Study. Diabetologia 1994; 37: 278-285
14. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853
15. van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK, Kofinis A, Rottiers R, Porta M, Chaturvedi N. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005; 28: 1383-1389
16. von Stackelberg J-M. AOK im Dialog, DMP - Höhere Versorgungsqualität für chronisch Kranke. Frankfurt, KomPart Verlagsgesellschaft mbH & Co KG, 2005: 31-37